Literature DB >> 7024081

Role of ovarian hormones in the long-term control of glucose homeostasis. Interaction with insulin, glucagon and epinephrine.

H Ahmed-Sorour, C J Bailey.   

Abstract

This study examines the effects of ovarian hormones on the glycaemic actions of insulin, glucagon and epinephrine. Ovariectomized adult female mice were treated with replacement doses of oestradiol, progesterone, both hormones combined or vehicle only for 15 weeks. Compared with intact control mice, ovariectomy did not significantly alter insulin-induced hypoglycaemia. However, treatment with oestradiol or progesterone alone, but not in combination, increased the hypoglycaemic action of insulin. The hyperglycaemic effect of glucagon and epinephrine was increased by ovariectomy and reduced by the ovarian hormone treatments. The results indicate that oestradiol and progesterone individually synergize the hypoglycaemic action of insulin, but mutually antagonize each other in this respect. Oestradiol and progesterone, individually and in combination, appear to suppress the glycogenolytic action of glucagon and epinephrine.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7024081     DOI: 10.1159/000179307

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  14 in total

1.  No effect of menstrual cycle phase on glucose kinetics and fuel oxidation during moderate-intensity exercise.

Authors:  Tracy J Horton; Emily K Miller; Deborah Glueck; Kathleen Tench
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-04       Impact factor: 4.310

2.  Sex differences in forebrain estrogen receptor regulation of hypoglycemic patterns of counter-regulatory hormone secretion and ventromedial hypothalamic nucleus glucoregulatory neurotransmitter and astrocyte glycogen metabolic enzyme expression.

Authors:  A S M Hasan Mahmood; M M Uddin; M M H Ibrahim; S K Mandal; H N Alhamami; K P Briski
Journal:  Neuropeptides       Date:  2018-10-26       Impact factor: 3.286

Review 3.  Exploring the causes and consequences of maternal metabolic maladaptations during pregnancy: Lessons from animal models.

Authors:  Amanda N Sferruzzi-Perri; Jorge Lopez-Tello; Tina Napso; Hannah E J Yong
Journal:  Placenta       Date:  2020-01-31       Impact factor: 3.481

4.  Renoprotective impact of estrogen receptor-α and its splice variants in female mice with type 1 diabetes.

Authors:  Debra L Irsik; Melissa J Romero-Aleshire; Erin M Chavez; Rachel W Fallet; Heddwen L Brooks; Pamela K Carmines; Pascale H Lane
Journal:  Am J Physiol Renal Physiol       Date:  2018-04-18

Review 5.  Oestrogens and insulin secretion.

Authors:  I F Godsland
Journal:  Diabetologia       Date:  2005-09-29       Impact factor: 10.122

6.  Increased adipose tissue in male and female estrogen receptor-alpha knockout mice.

Authors:  P A Heine; J A Taylor; G A Iwamoto; D B Lubahn; P S Cooke
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

Review 7.  Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.

Authors:  I F Godsland; U Winkler; O Lidegaard; D Crook
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

8.  Ovarian suppression with a gonadotropin-releasing hormone agonist does not alter insulin-stimulated glucose disposal.

Authors:  Brian C Cooper; Cynthia K Sites; Peter R Casson; Michael J Toth
Journal:  Fertil Steril       Date:  2007-05       Impact factor: 7.329

9.  Expression of aquaporin 9 in rat liver and efferent ducts of the male reproductive system after neonatal diethylstilbestrol exposure.

Authors:  Anja Wellejus; Henrik E Jensen; Steffen Loft; Thomas E Jonassen
Journal:  J Histochem Cytochem       Date:  2007-12-23       Impact factor: 2.479

10.  Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver.

Authors:  G Bryzgalova; H Gao; B Ahren; J R Zierath; D Galuska; T L Steiler; K Dahlman-Wright; S Nilsson; J-A Gustafsson; S Efendic; A Khan
Journal:  Diabetologia       Date:  2006-02-04       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.